KYTX vs PDD · $488.8M cap vs P/E 8.4, rev $61.75B
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
KYTX does not have a complete income-statement cache yet.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
KYTX currently screens at market cap $488.8M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the KYTX and PDD stock pages for the full models.
Not investment advice.